Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials
Yuki Enoki,
Yuki Igarashi,
Yuki Watabe,
Kyoka Honma,
Yuto Suzuki,
Yukitaka Hayashi,
Kana Hiraoka,
Kazuaki Taguchi,
Kazuaki Matsumoto
Affiliations
Yuki Enoki
Corresponding author at: Division of Pharmacodynamics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.; Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Yuki Igarashi
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Yuki Watabe
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Kyoka Honma
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Yuto Suzuki
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Yukitaka Hayashi
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Kana Hiraoka
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Kazuaki Taguchi
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
Kazuaki Matsumoto
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan
